Mycobacterium tuberculosis: Macrophage Takeover and Modulation of Innate Effector Responses by Bhat, Khalid Hussain & Yaseen, Imtiyaz
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 2
Mycobacterium tuberculosis: Macrophage Takeover
and Modulation of Innate Effector Responses
Khalid Hussain Bhat and Imtiyaz Yaseen
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/intechopen.75003
Abstract
Macrophages mediate the first line of defense in the host against various intracellular path-
ogens. They are armed with several immune-effector mechanisms to detect and combat
pathogens. However, intracellular pathogens have developed strategies to overcome the
macrophage protective immune responses and colonize inside the macrophages. Tuberculo-
sis (TB), both pulmonary and extrapulmonary, is an infectious disease of global concern
caused by Mycobacterium tuberculosis. M. tuberculosis is a highly successful pathogen and has
acquired various strategies to downregulate critical innate-effector immune responses of
macrophages such as phagosome-lysosome fusion, antigen presentation, autophagy, and
inhibition of reactive oxygen (ROI) and reactive nitrogen (RNI) species to ensure its longer
survival inside the macrophages. In addition to these, the bacilli alsomodulate Tcell immune
response which can help the bacilli to survive inside the host for a long time. In this chapter,
we focus to describe important macrophage innate defense mechanisms and the signaling
that can influence T cell adaptive response and the strategies adopted by the bacilli to exploit
these signaling cascades to favor its replication and persistence inside the macrophages for
establishing a productive infection.
Keywords: Mycobacterium tuberculosis, monocytes/macrophages, macrophage effector
response and signaling cascades, host responses and M. tuberculosis pathogenesis
1. Introduction
Macrophages mediate the first line of defense in the host against various intracellular pathogens
[1]. They are armed with several immune-effector mechanisms to detect and combat pathogens
[2, 3]. However, intracellular pathogens have developed strategies to overcome the macrophage
protective immune responses and colonize inside the macrophages. Tuberculosis (TB), is an
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infectious disease caused by a extremely successful pathogen, Mycobacterium tuberculosis, as it
has evolved numerous clever strategies over time to modulate important macrophage innate-
effector immune responses such as phagosome maturation, antigen presentation, inhibition of
reactive oxygen (ROI) and reactive nitrogen (RNI) species, and autophagy to ensure its survival
inside the macrophages [4–6]. In addition to these, the bacilli also modulate T cell immune
response which can help the bacilli to survive inside the host for a long time [7]. In this chapter,
we focus to describe important macrophage innate defense mechanisms and the signaling that
can influence T cell adaptive response and the strategies adopted by the bacilli to exploit these
signaling cascades to favor its replication and persistence inside the macrophages for
establishing a productive infection.
2. Monocytes/macrophages
2.1. History and development
Eli Metchnikoff’s obsession, the “phagocyte” [phagos-to eat, cyte-cell], is a constituent of
Ludwig Aschoff’s reticuloendothelial system (RES) [8]; the macrophage plays a key role at
almost all the stages of immune response including innate and adaptive immune responses.
Macrophages provide the first line of defense against the invading pathogens. In addition to
protecting the body against attacks by foreign organisms, macrophages regulate important
physiological functions. Their role in homeostasis has been well established. Macrophages
clear almost 2  1011 erythrocytes per day. This enormous metabolic turnover is crucial for
iron homeostasis and to prevent formation of toxic intermediates [9]. Macrophages are
equipped with scavenger receptors such as phosphatidylserine receptors, thrombospondin
receptor, integrins, and complement receptors to clear the cell debris and rapidly remove the
apoptotic cells to help in tissue-remodeling processes. Antigens from the engulfed cells are
presented along with the MHC molecules to activate the adaptive immune responses [10].
Thus, macrophage serves as a professional scavenger of the dying cells that not only clears the
corpus but also regulates the immune system.
The circulating monocytes that are considered to be the developmental intermediates between
bone marrow precursors and tissue macrophages emigrate from the blood vessels and differ-
entiate into tissue macrophages [11]. Macrophages and monocytes originate from hematopoi-
etic stem cell-derived progenitors with myeloid-restricted differentiation potential [1]. The
bone marrow progenitors, monocytes, and macrophages collectively were classified into
mononuclear phagocytic system, a concept pioneered by van Furth [12]. Monocytes are ini-
tially identified by the expression of CD14 molecules and lack of CD16 expression on the
surface. These monocytes are termed as “classical monocytes” with CD14++CD16 phenotype
and accounting for about 90% of human blood monocytes. However, later studies have proved
the expression of CD16 on the surface of some cell populations that were termed as “non-
classical monocytes” with CD14+CD16++ phenotype [13]. The replenishment of tissue macro-
phages with the circulating monocytes is well established, but in some instances like
in microglial cells of brain, local proliferation of macrophages has been established. Owing
to the adaptability and plasticity of macrophages and their responsiveness to different
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microenvironments in different tissues such as lung, spleen, liver, gut, and brain, a consider-
able heterogeneity exists among them [14]. For example, lung alveolar macrophages being
constantly exposed to a variety of antigens, express a high level of pattern recognition recep-
tors and scavenger receptors on the surface. In contrast, the macrophages of the gut exhibit
high levels of phagocytic and antibacterial activities compared to other macrophages [15].
2.2. Macrophage activation
Activation is defined as the acquisition of competence to execute a complex function [16].
The factor responsible for macrophage activation was found to be the interferon-gamma
(IFN-γ) produced by CD8+ cytotoxic T (Tc1) cells, CD4+ T helper 1 (Th1) T cells, and natural
killer (NK) cells. IFN-γ activation leads to conversion of macrophages to potent phagocytotic
cells with increased production of reactive oxygen intermediates and reactive nitrogen inter-
mediates, superoxides and proinflammatory cytokines helping the cells to efficiently kill
the intracellular pathogens. These macrophages have increased antigen presentation activity,
thus they mount an effective immune responses in the host. The IFN-γ-mediated activation
is known as “classical activation” and the macrophages are classified as “type 1 or M1
macrophages” [3, 18] (Figure 1). IFN-γ stimulation is not enough for the classical activation
of macrophages, and may require additional stimulation by TNF-α. As TNF-α is not
Figure 1. Schematic diagram showing different types of macrophages. Th1 cytokines primarily produced by T cells,
natural killer (NK) cells and other antigen presenting cells (APC) result in the development of classically activated (M1)
macrophages having microbicidal functions. While Th2 cytokines result in the development of macrophages that pre-
dominantly perform tissue repair and anti-inflammatory functions (M2), T reg cells result in the development of regula-
tory macrophages having immunosuppressive activities.
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constitutively present in the environment, specific receptor ligands like lipopolysaccharides
(LPS) and various microbial ligands may help in the induction of endogenous expression of
TNF-α in macrophages [19, 20].
The T helper 2 (Th2) type of cytokines, IL-4 and IL-13, induce a response distinct from the
one induced by IFN-γ with distinct set of genes being expressed and is known as “alter-
native activation” pathway of macrophages, and the cells are named as “alternative
activated type 2 or M2 macrophages” [21]. In addition to T cells and B cells, IL-4 and IL-
13 are also produced by various other cells such as mast cells, basophils, eosinophils, NK
T cells, and macrophages that are involved in regulation of innate immune responses.
Hence, alternative activation can be of both innate and acquired origin. Other than these
two cytokines, immune complexes, IL-10, glucocorticoid, or secosteroid (vitamin D3) hor-
mone can also contribute to the activation of M2 macrophages [22–25]. M2 macrophages
are characterized by expression of scavenger, mannose [26], and galactose-type receptors,
and markers such as dectin-1, arginase 1, Ym1, and FIZZ1 [27]. The M2 macrophages
have anti-inflammatory properties and are associated with allergic and anti-parasite
responses, and are thought to regulate humoral immunity [27, 28]. The alternatively
activated macrophages are found to be recruited to wounds and other sites of tissue
injury and are programmed to perform a wound healing function by expressing arginase.
These macrophages are termed as “repair macrophages” or “wound healing macro-
phages” [19, 29, 30]. The M1 and M2 macrophages thus represent two populations of cells
with different biological functions [31]. For example, the M1 macrophages, but not the M2
macrophages, produce high levels of reactive oxygen and nitrogen intermediates) and
inflammatory cytokines (IL-1β, TNF-α, IL-6), and have low arginase activity, express
relatively high levels of CD86, and are efficient APCs. While the M1 cells have an IL-
12high, IL-23high, and IL-10low phenotype and play an important role in inducing a domi-
nant Th1 response and provide resistance against intracellular pathogens and tumors [17,
23, 32–34], the various forms of M2 macrophages share an IL-12low and IL-23low pheno-
type, virtually devoid of the co-stimulatory molecules and fail to mount a strong T cell
proliferation [35, 36]. The innate and adaptive immune responses can also lead to the
production of the “regulatory macrophages” (M reg) (Figure 1). The M reg cells are
shown to be very stable in their phenotype and have regulatory activity. These cells are a
novel type of suppressor macrophage which induces tolerance during organ transplanta-
tion. They have potent T cell suppressive function [37] and inhibit production of the IL-12
cytokine [38].
The activated macrophages exhibit a profound change in their capacities and functions. In
addition to other physiological changes, there is a rapid membrane turnover found in case of
macrophages even in the resting stage. This membrane flow is enormously increased in the
activated state as a result of enhanced phagocytic activity and lysosomal degradation of the
ingested material [39, 40]. Phagosomes undergo a series of maturation steps resulting in
gradual acidification and increase in the hydrolytic activity. In addition to hydrolases, lethal
superoxide generating enzyme activities become prevalent toward the end of phagosome
maturation [40]. The NADPH oxidase activity of the enzyme complex leads to formation of
H2O2 in presence of superoxide dismutase enzyme [41].
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3. M. tuberculosis: infection and disease
Mycobacteria are rod-shaped bacteria of phylumActinobacteria mostly found in soil or water. The
M. tuberculosis, M. bovis, M. africanum, M. microti, M. canettii,M. caprae,M. pinnipedii, andM. mungi
all cause TB disease and are classified as M. tuberculosis complex [42–44]. The M. tuberculosis, a
facultative intracellular pathogen, was discovered by Robert Koch in 1882 as a causative agent for
TB disease in human, those days commonly known as “consumption” or “white plague” [45].
Different strains of M. tuberculosis differ in virulence and in distribution among different human
populations. M. tuberculosis W-Beijing strain is one of the most pathogenic strains distributed
throughout the world [46, 47]. The use of chemotherapeutics against M. tuberculosis has resulted
in the appearance of drug-resistant strains [48]. Multiple drug-resistant (MDR), extensive drug-
resistant (XDR), and total drug-resistant (TDR) strains are becoming increasingly prevalent [49–
52]. TheM. tuberculosis bacteria are highly aerobic, non-sporulating, and non-motile bacteria. They
have a high guanine plus cytosine (G + C) content (61–71%) in their genomic DNA, and are
characterized by the presence of large hydroxylated branched-chain fatty acids called mycolic
acids in their cell envelope [53, 54]. Although they have been classified with other Gram-positive
actinomycetes due to their lack of an outer cell membrane, mycobacteria stain weakly with crystal
violet and are resistant to decolorization with acid-alcohol solutions after staining with alkaline
arylmethane dyes such as carbol fuchsin, hence called acid-fast. M. tuberculosis primarily infects
not only lungs (pulmonary) but can also colonize other body parts (extra-pulmonary). The symp-
toms of TB disease include chronic cough, bloodwith sputum, weight loss, fever and night sweats,
cavitation, and fibrosis [55, 56].
TB is a major public health burden. Despite the availability of effective short-course chemother-
apy (DOTS) andM. bovis bacillus Calmette-Guérin (BCG) vaccine, more than 9 million new cases
of M. tuberculosis infections are reported every year that accounts to more than 2 billion (one
third of world population) being positive for the infection, resulting in 2 million deaths every
year and one fifth of all adult deaths in developing countries. Developing countries are the most
affected by this pandemic with 30% of the cases being reported from Africa and 55% from Asia.
India and China alone are harboring 35% of the cases. With no new drug in use for a while, TB
has become increasingly resistant to drugs and multi-, extensive-, and total-drug resistant TB
have emerged. Interaction with other infectious diseases like HIV is making it challenging to
handle the disease [57]. Other pathological conditions and risk factors associated with TB such as
diabetes mellitus, renal diseases, hematological disorders and use of anti-TNF-a drugs has
complicated the problem [58]. Socioeconomic factors and variable efficacy of BCG vaccination
are also responsible for further aggravating the already complex problem [55, 59].
After infection with M. tuberculosis, an individual may not necessarily develop active disease.
In case the immune system is competent enough, an individual will either clear the infection or
remain latently infected with no clinical signs of disease throughout the life or can have
reactivation of TB during weakening of immune system or co-infection with other pathogens
like HIV [60, 61]. The molecular factors or environmental conditions that influence the pro-
gression of latent phase to active disease are not well understood. During latency, the M.
tuberculosis bacterium remains inside the infected macrophages in granulomas. These tiny
granulomas show no clinical symptoms although they may be visible in chest X-rays and give
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positive tuberculin skin test [62, 63]. In 5% of the cases where immune system is weakened, the
microscopic primary lesion progresses to a larger primary caseous lesion. The caseation of the
primary lesion may lead to hematogenous spread of bacteria causing miliary TB or
extrapulmonary TB, where the infection spreads to liver, spleen, and kidneys [63]. In case the
bacteria find their way into brain, they may cause tuberculous meningitis [63]. Patients with
active pulmonary TB are diagnosed most commonly by sputum smear microscopy where
bacteria are directly observed under microscope in the sputum samples of patients or culturing
the samples to check for colony forming units and by chest X-ray. Diagnosis of extrapulmonary
TB patients is carried out by tissue biopsy, urine culture, cerebrospinal fluid test, CT scan, or
MRI. Latent TB has long been diagnosed by tuberculin skin test; however, its specificity has
been questioned due to false positive results as a result of infection with other non-tuberculous
bacteria or prior vaccination with BCG [64, 65]. Therefore, in recent years, interferon gamma
release assays (IGRAs) have been used as an alternative for the diagnosis of both latent TB
infection and active TB cases [66].
4. Infection of macrophages with M. tuberculosis and host immune
responses
4.1. The host-bacilli interplay
M. tuberculosis infection is transmitted via aerosol route. Prolonged and close contacts with
infected patients result in the transmission of the pathogen in healthy persons as it is known that
survival of the bacterium ranges from one to few hours in the aerosol droplets, which are about
1–2 μm or less size [67, 68]. Once the pathogen enters the respiratory track, it is finally engulfed
by the alveolar macrophages of lung through surface receptors. A number of studies reveal that
complement receptors and complement-mediated opsonization are majorly involved in the entry
of M. tuberculosis inside the macrophages. One of the most important receptors for mycobacteria
is complement receptor 3 (CR3), while other receptors such as CR1 and CR4, mannose receptor,
surfactant protein A receptor, CD14, Fcγ receptor, scavenger receptors, etc., have also been
implicated in phagocytosis and internalization of the bacteria inside the macrophages [69–71].
For alveolar dendritic cells (DC), DC-specific intercellular adhesion molecule 3-grabbing
nonintegrin (DC-SIGN) is the main receptor for M. tuberculosis [72]. Though complement recep-
tors are found to be important for phagocytosis of both the avirulent and virulent strains of M.
tuberculosis, the decline of mannose receptors was found to be associated with reduced binding
of only the virulent strains [73]. The mycobacterial surface glycoprotein, mannose-capped
lipoarabinomannan (Man-LAM) is recognized by the C-type lectins and the macrophage man-
nose receptor (MMR) [74, 75]. An important role of toll-receptors, mainly the TLR2, has been
demonstrated for the attachment of mycobacteria to macrophages [76]. Interestingly, a large
number of surface proteins ofM. tuberculosis interact with the TLR2 receptors [76]. After binding,
the bacteria are internalized and engulfed into phagosomes, where they can be killed by several
defense mechanisms. Thoma-Uszynski et al., (2001) have shown a role of the TLR2-triggered
signaling to induce cytotoxicity against M. tuberculosis in alveolar macrophages [77]. Soon after
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the first contact of M. tuberculosis with alveolar macrophages, generally a robust proinflam-
matory immune response is induced that confers protection against the bacilli. It is observed
that dampening of the proinflammatory signaling can increaseM. tuberculosis infection burden in
mice [78]. Following intracellular infection, adaptive immunity is generated against the invading
pathogen via activation of CD4+ T cells and CD8+ T cells. Many times this adaptive immunity
fails to provide a sterilizing immunity resulting in longer persistence of the infection and
reactivation of M. tuberculosis bacteria. The bacilli are found to inhibit the class I, class II, and
cross presentation of mycobacterial antigen to T cells, thus avoiding immune recognition by T
cells. It has been observed that integrity of bacterial cell wall is important for M. tuberculosis in
evading adaptive responses. At the site of infection, proinflammatory IFNs and cytokines are
secreted, which help in the recruitment of CD4+ T cells, CD8+ T cells, natural killer T cells, and
neutrophils [79]. Many a time, the induction of acquired immune response againstM. tuberculosis
is slow and the establishment of infection wins against the induction of full-fledged response [4,
80]. The cell-mediated immune response initiated at the sites of infection is found to be modu-
lated by the bacilli. After establishing the infection, the M. tuberculosis antigens move with the
help of alveolar dendritic cells to the draining lymph node, which leads to the stimulation of
naive CD4+ T cells. The active role of CD4+ T cells in fighting againstM. tuberculosis infection was
proposed in 1974 in mice. In addition, the HIV mediated depletion of CD4+ T cells and a
defective macrophage activation in some genetic disorders has been associated with worst TB
prognosis [4, 81]. Furthermore, CD4/ knockout and MHC-II/ knockout mice have been
found to be prone to infection by M. tuberculosis [82]. The inhibitory effect of stimulated Th1-
type CD4+ T cells is by the production proinflammatory cytokines such as IFN-γ and TNF-α,
which inhibit bacillary growth [81]. In comparison, when stimulated in the context of MHC class
II, Th2-type CD4+ T cells proliferate and produce anti-inflammatory cytokines such as IL-4, IL-5,
and IL-10, which are favorable for the bacilli to establish a productive infection [79, 81]. Many
studies indicate thatM. tuberculosis bacilli suppress the pro-inflammatory cytokines such as IL-12
and IFN-γ and activate production of anti-inflammatory cytokines like IL-10 to skew the anti-
mycobacterial immune response from a protective Th1 to a non-protective Th2-type. At the early
stages of infection, activation of CD8+ T cells by APC leads to bacterial killing. However, the role
of CD8+ T cells at later stages of infection has not been established [82]. The CD8+ T cells can also
be activated by the cross presentation of M. tuberculosis antigen along with MHC class I mole-
cules. Post infection, CD8+ T cells migrate to the infected tissue and produce IFN-γ. This migra-
tion of CD8+ T cells is a characteristic of the granuloma establishment [83]. Higher bacterial load
was found in mice deficient in some of the components of class I presentation and CD8+ T cell
activation pathways like β2 microglobulin, transporter associated with antigen processing pro-
tein (TAP), and T cell co-receptor CD8α [83].
4.2. Formation of granuloma
M. tuberculosis infection of alveolar macrophages leads to the activation of alveolar dendritic
cells which migrate to lymph nodes. In the lymph nodes, CD4+ T cells, CD8+ T cells, and γδ T
cells proliferate in response to activation by the alveolar dendritic cells. At the site of infection,
the resulting immune activation leads to a microenvironment of cytokines and chemokines
which induces the expression of integrins, selectins, and addressins on the surfaces of
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lymphocytes and endothelial cells. This facilitates a mass migration of immune cells resulting
in the formation of a focus of immune cells called “tubercle” or granuloma around the primary
site of infection. Macrophages and giant nucleated epithelioid cells form layers around the
granuloma. While the inner core of granuloma becomes necrotic, the outer surface is covered
by fibrous tissue and vasculature is developed. The granuloma is formed by the immune
system to contain M. tuberculosis to the site of infection and not allowing its spread to other
normal tissues. The latent infection may persist and remain dormant for life time without
proceeding to diseased condition [79, 84]. At the nascent stage of granuloma, the recruitment
of uninfected and susceptible macrophages to the site of infection may lead to their infection
due to apoptosis of the existing infected macrophages. This may lead to initial proliferation of
the bacteria till equilibrium is attained by containment of bacteria in the granuloma and
control of infection due to adaptive immune response. Some of the newly infected macro-
phages egress from granuloma and nucleate the formation of new granulomas at other
uninfected parts of the lungs (Figure 2) [85]. It has been noticed that bacterial dissemination
and rapid disease progression are related with larger necrotic granulomas [57], however,
containment of disease is found to be associated with smaller solid granulomas [86]. Further-
more,M. tuberculosis contributes to the formation of granuloma by secreting pathogenic factors
Figure 2. Development of granuloma. Immediately post infection, innate immune response is induced. The immune
activation and apoptosis of infected cells lead to a microenvironment of cytokines and chemokines which attracts more
uninfected macrophages. At this stage, some newly infected macrophages can migrate to uninfected areas and initiate the
formation of new granulomas. This results in initial proliferation of the bacilli. Adaptive immunity although inherently
slow in development, checks further spread of infection resulting in an equilibrium state. Immunocompromization of an
individual at later stages can lead to caseation of the granuloma and the bacteria are rapidly disseminated.
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as RD1 deficient bacteria show attenuated granuloma formation and macrophage migration to
the primary site of infection in zebra fish model [85]. Studies in non-human primate, rabbit,
and guinea pig models indicate hypoxic inside the environment of granuloma. In combination
with nutrient deficiency, hypoxia induces a dormancy program in the bacilli which is charac-
terized by changes in gene expression and alterations in the bacterial metabolism. Hence
probably a latent infection is established which may be activated latter during immunocom-
promization. Thus, after entry in the human lungs, M. tuberculosis faces a series of host defense
attacks. However, the overall outcome of infection with M. tuberculosis depends on the balance
between (i) outgrowth and killing of M. tuberculosis and (ii) the extent of tissue necrosis,
fibrosis, and regeneration.
4.3. Phagosome maturation response
After phagocytosis, M. tuberculosis bacteria reside inside the endosomes of the macrophages.
Normally, endosome fuses with lysosome to degrade the pathogens, but M. tuberculosis bacteria
are capable of inhibiting the process of phagosome maturation, as a result of which acidification
of phagosome is compromised. The intracellular survival and persistence of the tubercle bacilli
rests upon its ability to prevent phagosome-lysosome fusion, thus avoiding degradation, antigen
processing, and cidal properties of the phagolysosome. Lipoarabinomannan capped with man-
nose (Man-LAM), a cell wall component of M. tuberculosis and SapM, a phosphatidylinositol 3-
phosphate (PI3P) phosphatase secreted by the bacilli, are found to interfere with phosphoi-
nositide metabolism of macrophages by depleting PI3P in phagosome [87, 88]. The latter is used
as a docking molecule by peripheral proteins of lysosomes [7]. M. tuberculosis also possess
protein phosphatases (Ptp A and B) that may interfere with host trafficking process possibly by
modulating vacuolar sorting proteins [89].
The transport of M. tuberculosis containing vacuoles to lysosomes is mediated by a class of
GTPases called Rab GTPases. A phagosome, when it normally matures into the phagolysosome,
undergoes a transition between the stages marked by early endocytic Rabs (e.g., Rab5) and late
endocytic GTPases (e.g., Rab7). Under normal circumstances, Rab proteins are actively recruited
to the vesicles and assembled resulting in fusion of different vesicular compartments. In case ofM.
tuberculosis infection, it was observed that recruitment of Rab7 to the vacuole containing M.
tuberculosis was inhibited while Rab5 was recruited normally indicating a maturation block
between a Rab5 and Rab7 stage in infected macrophages that causes inhibition of phagosome-
lysosome fusion. The exchange of Rab5 protein with Rab7 was later named as Rab conversion [90,
91]. Rab5 interacts with early endosomal autoantigen 1 (EEA1), which in turn interacts with
phosphatidylinositol 3-phosphate (PI3P). Thus, inhibition of PI3P production by M. tuberculosis
appears to be also critical for the inhibition of maturation of endolysosomes [91]. A series of Rab
proteins are bind to phagosomes to ensure its acidification and recruitment of cathepsin D, while
the process is severely inhibited in case of M. tuberculosis infection. A soluble eukaryotic-like
protein kinase PknG of pathogenic M. tuberculosis is shown to be crucial for the prevention
of phagosome-lysosome fusion [92]. A recent study has also shown that the M. tuberculosis
secretory proteins, ESAT-6 and CFP-10 encoded by RD1 region play crucial roles in preventing
phagolysosomal fusion [93]. Genetic screens using comprehensive mutant libraries of M.
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tuberculosis and BCG suggest that additional mycobacterial products directly or indirectly can
influence trafficking processes which probably are important for intracellular survival [94, 95].
Coronin1, exclusively recruited to M. tuberculosis containing phagosome, is an important host
factor that specifically prevents the lysosomal delivery and death of mycobacteria inside macro-
phage [96]. Coronin1 prevents phagosome-lysosome fusion by regulating Ca2+-dependent signal-
ing processes when macrophages are infected with M. tuberculosis [97]. The Nramp1 (natural-
resistance-associated macrophage protein 1) gene involved in macrophage activation and myco-
bacterial killing [98] becomes part of the phagosome following phagocytosis and displays reduced
phagosomal maturation and acidification [99].
A family of IFN-γ-inducible GTPases, also called immunity-related GTPases (IRGs), was
found to play a critical role in host innate immunity against intracellular pathogens [100–102].
A member of IRG family, 47 kDa Irgm1 (also called LRG-47) protein (which is strongly
inducible by IFN-γ and M. tuberculosis infection in mice) is an important anti-M. tuberculosis
protein [100]. The anti-mycobacterial role of Irgm1 is due to its interaction with phosphatidy-
linositol-3,4-bisphosphate (PtdIns (3,4)P2) and PtdIns(3,4,5)P3 present on the phagosomal
surface harboring M. tuberculosis. Irgm1 also increases phosphorylation of lipids by
augmenting the PI3K activity. Normally, Irgm1 interacts with a membrane trafficking protein
Snapin, which interacts with SNARE to ensure the fusion of phagosomes with lysosomes
resulting in the elimination of bacilli. M. tuberculosis has developed a way to counter Irgm1
effect by exploiting a natural pathway of Irgm1 inhibition by Rab14 protein that is critical for
phagosome-lysosome fusion. It has been shown that the mycobacterial phagosomes recruit
and retain Rab14 [103]. Rab 14 is inhibited by unphosphorylated form of AS160 protein.
Manipulation of Rab14-pathway by M. tuberculosis is mediated by the activation of Akt1 that
phosphorylates AS160. Phosphorylated AS160 is unable to inhibit Rab14 hence leaving it free
to inhibit Irgm1 recruitment to phagolysosomal compartment resulting in the failure of
phagolysosome maturation (Figure 3) [103–105]. The fusion of phagosomes with lysosomes
has been shown to be dependent on Ca2+ ions. Ca2+ ions and Ca-binding protein calmodulin
are critical for the delivery of lysosomal components to phagosomes using PI3P-dependent
pathways. Blockade of Ca2+/calmodulin pathway by M. tuberculosis is also found to be one of
the ways to block phagosomal maturation [70].
4.4. Autophagy
Autophagy (also called xenophagy) is an evolutionary conserved basic homeostatic mechanism
of a cell to digest intracellular organelles and large protein aggregates that are difficult to digest
by normal proteasomal pathway. The engagement of TLRs with mycobacterial ligands induces
autophagy using both MyD88-dependent and TRIF-dependent pathways [106, 107]. This sug-
gests that autophagy is an effector of innate immune response. The IFN-γ induces IRG proteins
that are mainly involved in induction of autophagy and elimination ofM. tuberculosis bacilli [108]
and polymorphism at IRG locus is shown to be associated with resistance toM. tuberculosis [109].
Many autophagy-associated proteins are shown to be involved in phagosome-lysosome fusion
process [110]. Expression of a number of host genes involved in autophagy is shown to be
modulated at the onset of M. tuberculosis infection. The pathogen has therefore acquired
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mechanisms to subvert the autophagy to induce a favorable condition for its persistence inside
the host [111]. M. tuberculosis can also inhibit autophagy by skewing the immune response
toward the Th2-type. While proinflammatory cytokines such as TNF-α and IFN-γ promote
autophagy, Th2 cytokines such as IL-4 and IL-13 inhibit autophagy in human and murine
macrophages, and this is dependent on the Akt-STAT6-signaling pathway [112]. Autophagy is
known to help in antigen presentation via both MHC class I and class II pathways and, by
inhibiting autophagy, M. tuberculosis also achieves the goal of suppression of MHC class I- and
class II-mediated antigen presentation [112]. Vaccines that are designed to elicit a strong
autophagic response can prove to be effective against latent TB infection and also drugs designed
to modulate autophagy can be effective against the drug-resistant strain ofM. tuberculosis [113].
4.5. Apoptosis
Macrophages use apoptosis as an effector mechanism to eliminate M. tuberculosis and to con-
strain the spreading of infection [114]. The apoptotic vesicles are readily engulfed by the neigh-
boring dendritic cells. The dendritic cells in turn activate CD8+ T cells by cross-presenting the
processed antigens in the context of MHC class I. This results in an effective immune response
against the bacilli. Necrosis, however, is favorable for the dissemination of bacteria and spread of
infection. Hence, M. tuberculosis has developed mechanisms to suppress apoptosis and favor
necrosis during active infection state [6, 63, 115, 116]. Inhibition of host cell apoptosis by M.
tuberculosis has been implicated as a potential virulence mechanism. In fact, an inverse correla-
tion between virulence of mycobacterial strains and their capacity to induce apoptosis has been
reported [114]. Infection with virulentM. tuberculosis strain H37Rv is found to be associated with
Figure 3. Critical balance between Rab14 and Irgm1 is important to counter M. tuberculosis infection. Pathogen results in
the production of phosphatidylinositol-3,4-bisphosphate (PtdIns(3,4)P2) and PtdIns(3,4,5)P3 which act as a docking site
for Akt1. The phosphorylated Akt1 phosphorylates AS160 which is inactive and is unable to deactivate Rab14. The active
Rab14 blocks the phagosome maturation. PdlIns also recruit Irgm1 which along with Snapin protein may help in
maturation of phagosomes and elimination of intracellular bacteria.
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reduced expression of several pro-apoptotic genes and increased expression of the anti-apoptotic
gene as compared to uninfected macrophages [117]. Studies using H37Rv and H37Ra strains of
M. tuberculosis to infect alveolar macrophages have indicated that although both could induce
apoptosis, the virulent H37Rv induce less apoptosis than the avirulent H37Ra by upregulating
expression of the anti-apoptotic gene Bcl-2 in macrophages [118]. TNF-α is shown to play
important role in host cell apoptosis infected with avirulent H37Ra strain [114, 119]. Also, the
role of Bfl-1/A1 is realized in inhibition of apoptosis byM. tuberculosis, as decreased intracellular
H37Rv growth was observed in Bfl-1/A1 siRNA-treated macrophages [120]. These cells show
enhancement of phagosome-lysosome fusion and Caspase-3 activity indicating that expression
of Bfl-1/A1 in H37Rv-infected macrophages provides the bacteria a survival strategy to over-
come host defense. Nuclear factor-kappaB (NF-κB) activation is shown to play an essential role
in the inhibition of host cell apoptosis by M. tuberculosis H37Rv [119]. Infection of macrophages
with virulentM. tuberculosis confers resistance to apoptotic stimuli like Fas ligand (FasL) or TNF-
α by reducing the cell surface expression of Fas receptors or secreting soluble TNF-α-receptor,
respectively [121, 122]. Interestingly, Divangahi et al. have shown that virulent M. tuberculosis
strains inhibit the production of prostaglandin E2 by interfering with lipoxigenase pathway
leading to inhibition of apoptosis and promotion of necrosis [115]. The other mechanism by
which M. tuberculosis could possibly inhibit apoptotic process is via the nuoG gene, which can
neutralize the NOX-2-mediated increase in ROS and TNF-α production in phagosomes
containing M. tuberculosis thereby inhibiting apoptosis [123, 124]. Also, secA2 and pknE play
roles in resistance against apoptosis as mutants of these genes induce more apoptosis in macro-
phages as compared to the wild-type M. tuberculosis strains [124–126].
4.6. Reactive oxygen and nitrogen intermediates (ROIs and RNIs)
ROIs and RNIs are produced in cells like macrophages in response to proinflammatory cyto-
kines [127, 128]. ROIs and RNIs being small molecules defuse easily through the membranes
and have a detrimental effect on the pathogens been engulfed in phagocytic vacuoles [129].
Studies have indicated that these molecules are important in providing innate host defense
against M. tuberculosis [4, 129]. ROIs are produced by phagocytes, particularly the polymor-
phonuclear leukocytes and the activated macrophages, while RNIs are produced mainly by
the activated macrophages. ROIs (O2•ˉ, H2O2, OH
•,) are generated through the action of
phagocyte oxidase (also called NADPH-oxidase). They further react with halides and amines
to generate more reactive species (Figure 4). The important role of NADPH-oxidase in defense
against M. tuberculosis and other pathogens is proven by the susceptibility of mice deficient in
NADPH oxidase [129–131]. Children carrying mutations in gp91phox subunit of phagocyte
oxidase enzyme are found to be more susceptible to TB infection than normal population [132].
In macrophages, IFN-γ in synergy with the TNF-α induces production of nitric oxide (•NO)
with the help of inducible nitric oxide synthase (iNOS) (Figure 4). Not only does NO exert its
effects on its own but also reacts with ROIs and the reaction products like peroxynitrite (OONO¯)
and other reaction intermediates can be even more toxic [127, 133]. After production, NO is not
restricted to the area but readily defuses to other areas by using S-nitrosothiols, S-nitrosylated
proteins, and nitrosyl-metal complexes as transport vehicles. NO produces heterogenous and
diverse effects owing to its non-specific reactivity with a number of regulatory proteins [129,
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134]. In mouse macrophages, activation of TLR2 by various bacterial ligands induces iNOS
promoter activity, production of NO, and killing of intracellular M. tuberculosis. However,
protective role of NO in human TB is controversial. An essential role of NO/iNOS in anti-
mycobacterial immunity was established by infection studies using iNOS knock-out mice [135,
136]. Mouse homozygous for knock-out allele for iNOS gene (iNOS/) when challenged with
M. tuberculosis showed a very high susceptibility to infection [135]. Although most of the
studies were conducted in mouse model, recent studies reveal that NO/iNOS is also important
in killing the bacteria in human TB [134, 137, 138]. The iNOS activation through TLR2 pathway
was found to enhance the killing of intracellular M. tuberculosis [77, 139]. All these studies
indicate that probably iNOS also plays crucial role in anti-mycobacterial immunity in human.
A comparative study of mice deficient either in phagocyte oxidase or in iNOS showed higher
anti-mycobacterial activities by RNIs as compared to ROIs [131]. ROIs and RNIs damage the
DNA and react with variety of other chemical moieties such as Fe-S clusters, tyrosyl radicals,
hemes, sulfhydryls, thioethers, and alkenes to inactivate important components of the invad-
ing pathogens to compromise its survival inside the host.
Figure 4. Regulation and function of iNOS during M. tuberculosis infection: Th1 cytokines like IFN-γ, TNF-α and IL-1β
produced by Th1 T cells or antigen-presenting cells (APC) induce nitric oxide synthase (iNOS) enzyme. IL-4 and IL-13
secreted by Th2 cells negatively regulate iNOS expression. The products of phagocyte oxidase (Phox) and iNOS react and
produce even more toxic intermediates like peroxynitrite against M. tuberculosis. NO also gives rise to sulfenic acid and
nitrosothiols on reaction with sulfhydryl groups.
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Like other effector mechanisms, M. tuberculosis has evolved effective strategies to counter RNIs-
and ROIs-mediated toxicity. The inhibition of the recruitment of iNOS to the infected phagosome
would be one of the ideal strategies used by the bacilli [140]. EBP50, a scaffold protein in
activated macrophages, targets iNOS to phagosomes [141]. M. tuberculosis downregulate EBP50
in the infected macrophages thereby reducing the transport of iNOS to the infected phagosome
[141]. The bacteria also induce various genes to protect them from intracellular oxidative stress
[109]. For example, mycobacterial catalase peroxidase (katG) and alkyl hydroperoxide reductase
(ahpC) have role in antioxidant defenses, defend bacteria from intracellular oxidative stress [142,
143], and play roles in the virulence ofM. tuberculosis [144, 145]. It has been shown that virulence
of different clinical as well as recombinant strains of M. tuberculosis is correlated with varying
expression levels of the peroxidase enzymes [143, 144]. NO induces a low oxygen state (hypoxia)
in mycobacteria resulting in the overexpression of katG and ahpC [129, 146]. These genes were
also reported to be overexpressed in vivo during infection with mycobacteria and studies indicate
that these responses are abrogated in the phagosomal environment of NOS2/ mice [147–149].
Oxidative stress has been established to induce a two-component system called DosR/DosS,
consisting of a sensor histidine kinase DosS/DosT and a response regulator DosR [150–152]. The
system helps the bacilli to cope oxidative and other stress (S-nitrosoglutathione, ethanol, etc.)
conditions by initiating a complex response.
The DosR is characterized as a transcription factor responsible for transcription of the genes in
response to oxidative stress. Genes expressed during the stress response, like α-crystallin was
shown to carry sequences in the regulatory regions for DosR binding. In response to upstream
activation signals, DosR is phosphorylated at Asp54 that results in its binding to DNA via its
C-terminal domain and subsequent activation of DosR responsive genes. The sensor kinases,
DosS and DosT, respond to redox environment and hypoxia, respectively. Both the proteins
contain two GAF domains at N-terminal harboring a heme prosthetic group which interacts
with O2, NO or CO to induce autophosphorylation of the kinases and induce transcription of
genes by activating DosR (Figure 5). CO is produced by heme oxygenase (HO) enzyme of
macrophages. The enzyme is significantly upregulated during M. tuberculosis infection, oxida-
tive stress, hypoxia, and stimulation with various cytokines. The enzyme catalyzes degrada-
tion of heme to biliverdin, free iron, and produces sufficient physiological amount of CO to
induce dormancy program via binding primarily to DosS while DosT plays a little role in CO
sensing. Although CO is sufficient to induce dormancy regulon, it was established that iNOS is
required for optimal induction of response. Under aerobic condition, both the sensors are
blocked and maintain a basal level of DosR responsive genes, while in anaerobic condition,
they respond to the ligands and upregulate the DosR responsive genes to help the pathogen to
survive in the stress caused by ROIs and RNIs (Figure 5) [153–155].
4.7. Vitamin D3
Vitamin D has long been known to be one of the nutritional therapeutic agents with a capacity
to modulate the immune system in the case of anM. tuberculosis infection [156]. There has been
a greater incidence of TB during the spring/summer months in temperate countries like UK
[157], which can be correlated to a decrease in Vitamin D production on account of lower sun
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exposure in the winter months. Dietary composition also seemed to have a bearing with a
predisposition toward TB, since a study conducted on an immigrant Gujarati Indian popula-
tion in UK showed a marked increase in TB cases. It must be mentioned here that this
population is a vegetarian one and hence dietary intake of Vitamin D is markedly less [158].
The genetic reason for this preponderance has been worked out to be an association with the
VDR polymorphisms associated with the Gujarati Asian population concerned and Vitamin D
deficiency [159]. Various studies indicate that Vitamin D can help the body fight against M.
tuberculosis infections [160]. In a recent study, it has been found that patients administered with
Vitamin D in combination with antibiotics recovered from TB more quickly than the patients
administered with only antibiotics [161].
The mechanisms for a correlation of Vitamin D and TB are unknown, but it could be the
antimicrobial peptides in association of Vitamin D generated by the pattern receptor stimulation
in lieu of an infection with M. tuberculosis [162]. This stimulation then induces expression of
cathelicidin [162] and β-defensin 2 (DEFB4) [163]. Cathelicidin induces phagolysosomal fusion
which is necessary for killing of M. tuberculosis. In addition, 1,25(OH)2D, which is another
downstream biochemical produced in Vitamin D biosynthetic pathway, induces autophagy [160,
164] and downregulates metalloproteinases (MMPs) [165]. All these processes help in the forma-
tion of phagolysosomes and the subsequent killing of M. tuberculosis. Vitamin D also seems to
Figure 5. Role of NO, O2 and CO in regulation of DosR/S/T regulon: NO, O2, and CO are recognized in conjunction by
DosS and DosT in a concentration gradient-dependent manner. CO mostly signals via DosS than DosT, while O2 inhibits
both DosS and DosT. M. tuberculosis infection upregulates the production of heme oxygenase-1(HO-1) which metabolizes
heme to produce CO.
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affect the adaptive immune system albeit in a regulatory manner. This is ensued as the down-
stream product 1,25(OH)2D upregulates regulatory responses with a skew toward the Th2-
phenotype pattern. This can be ascertained by the anti-proliferative effects of 1,25(OH)2D on
CD4+ T cells [166]. It also seems to inhibit Th1 cytokine production [167, 168], while promoting T
regulatory function at the same time [169]. It also seemingly upregulates Th2 cytokine production
[170]. Studies using 1α,25-dihydroxyvitamin D3 indicate that vitamin D3 increases generation of
oxygen intermediates via NADPH-dependent phagocyte oxidase involving the phosphatidy-
linositol 3-kinase [171]. In addition to this, Vitamin D3 can downregulate transcription of
tryptophan-aspartate containing coat protein [172], which is important for the entry and survival
ofM. tuberculosis in human macrophages [173]. Thus, the role of proper nutrition in the control of
M. tuberculosis is evident. Vitamin D which has otherwise been associated as the “anti-cold”
Vitamin seems to have critical roles in the control of M. tuberculosis infection at the innate and the
adaptive levels of the immune system of the host.
5. Conclusion
TB remains a global pandemic and despite thorough and constructive measures to eradicate
TB, it has flourished and continues killing people. It has evolved into various MDR, XDR,
and TDR strains, notwithstanding the best healthcare available, which are resistant to the
obsolete group of drugs. This necessitates the need to find new drug targets as well as drugs
to counter the menace of TB. Therefore, it becomes imperative to understand the biology of
M. tuberculosis and the host response modulation mechanisms it has evolved. The same can
be achieved by dissecting the biochemical processes throughout the life cycle of the pathogen
and by understanding the host-pathogen interaction mechanisms in TB, both of which are
prerequisites for the development of effective anti-TB vaccines/drugs. More importantly, the
processes associated with the so-called “dormant stage” needs to be identified since this
stays the biggest challenge in identifying asymptomatic TB patients, and understanding this
Trojan can therefore escalate our steps to eradicate this menace by eons. In this chapter, we
have attempted to address various host processes that are subverted by M. tuberculosis to
survive inside its host as well as launch an assault when the host immune defenses are
weakened. Right from when M. tuberculosis enters inside the body, it counters the host innate
defenses by downregulating the oxidative burst inside the macrophages. It also subverts
other macrophage effector functions like inhibition of phagolysosomal fusion which is criti-
cal for the action of lytic enzymes and therefore forms an important block where it escapes
the host defenses. Most importantly, it modulates the host signaling targeting the PAMP
receptors, more importantly the TLR2 or to downregulate the proinflammatory signaling
cascade known to be detrimental for its intracellular survival. The adaptive responses are
similarly affected as one of the major mechanisms, viz. antigen presentation seems to be
downregulated. Both MHC class I and class II and even cross presentation are affected. This
results in a very less or delayed outcome of protective adaptive immune response which
again helps the pathogen to survive very efficiently inside the macrophages. It also affects
critical host processes like apoptosis which could clear the pathogen in a controlled manner
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without allowing it to spread. Downregulating the proinflammatory signaling cascade also
involves skewing the macrophage responses from a protective Th1- to a non-protective Th2-
type. This involves most importantly a shift in the cytokine secretion pattern which subverts
the host favorable macrophage signaling and effector functions in favor of the host. We have
described important pathophysiological events during M. tuberculosis infection and the vir-
ulence processes by which the bacilli can escape the macrophage surveillance mechanisms,
and use it as their safe refuge which may help in designing suitable interventions against M.
tuberculosis infection.
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